UNSPSC 51312504: Tiacrilast

This classification denotes a histamine-1 receptor antagonist with the molecular formula C12H10N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 74L3DXN051, chemically known as 2-propenoic acid, 3-(6-(methylthio)-4-oxo-3(4h)-quinazolinyl)-, (e)- but generally known as tiacrilast, which bears US NIH Compound Identifier 6435375. European Medicines Agency schedules Tiacrilast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10997MIG.

UNSPSC 51312504 Tiacrilast is a Commodity code that in recent state and local procurement practice maps to pharmaceutical products and drug-management systems rather than tiacrilast specifically. Seminole County, Florida's IFB60459723LAS solicitation, posted June 30, 2026 with a response deadline of July 26, 2023, sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive bidding. The county's scope calls for quarterly deliveries to the Seminole County Community Health Building in Sanford, with all shipping and delivery costs included in vendor pricing. Vendors must submit bids electronically through the county's e-Procurement Portal, meet drug-free workplace and E-Verify certification requirements, and maintain workers' compensation, commercial general liability, and professional liability insurance. The contract carries an initial two-year term with an option for one-year renewal and includes a three-month probationary period during which the county may terminate with or without cause.

The code shows minimal recent activity in the state and local market. The single posted opportunity originates from a Florida county health procurement office. Seminole County specified that bidders submit unit costs for each line item and comply with federal requirements including the Clean Air Act and Federal Water Pollution Control Act, suggesting potential FEMA funding for the contract. The solicitation included no explicit set-aside or disadvantaged-enterprise designations. Vendors must be legally authorized to work in the United States and subject to audits and record inspections for compliance verification.